Disappointing Joshua Buatsi Outpoints Parker in Manchester Fight
-
- By Andrea Cunningham
- 03 Oct 2026
Under a tenth of people eligible to benefit from obesity jabs including Wegovy are able to get them, warns the global health agency as it releases its initial recommendations on the drugs.
Given in excess of 1,000,000,000 people worldwide currently classified as obese, it is calling for increased and just access to GLP-1 medication.
Based on projections, over two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidance recognises that excess weight is a long-term condition that can be managed with comprehensive and ongoing support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and logistical bottlenecks are major barriers to broad access to the jabs that can aid individuals in losing substantial body mass, notes the organization.
Even under the current best projected scenario, the supply of GLP-1 therapies might only reach approximately 100 million people – fewer than 10% of eligible patients, according to the WHO.
The advice urges nations and manufacturers to increase access, by measures like patent sharing.
The intellectual property rights on semaglutide – the main ingredient of a leading brand – is due to expire in multiple countries in 2026.
GLP-1 drugs mimick a biological compound to reduce digestion speed, suppress the appetite and increase feelings of fullness so individuals eat less.
Individuals commonly start to lose weight after several weeks of starting on the regular doses.
Evidence points to people may see weight return after a year of halting the treatment, when their usual food cravings resume.
Being overweight or obese raises your chance for developing medical conditions, including type 2 diabetes, heart disease, stroke, and some malignancies.
Excess weight concerns people in countries worldwide and was linked to over three and a half million deaths worldwide in 2024, according to the WHO.
Elara Vance is a seasoned gaming journalist with over a decade of experience covering casino trends and slot machine innovations.